LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 24.81 | 84.90 | 1111 | 1769 | 0.6279 | 0.7984 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.51 | 84.90 | 22 | 1923 | 0.0114 | -0.2592 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.51 | 84.90 | 1017 | 1923 | 0.5288 | 0.7361 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.51 | 84.90 | 799 | 1923 | 0.4155 | 0.6455 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 26.51 | 84.90 | 1118 | 1923 | 0.5813 | 0.7730 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.21 | 84.90 | 21 | 2091 | 0.0100 | -0.2608 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.21 | 84.90 | 1006 | 2091 | 0.4810 | 0.7071 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.21 | 84.90 | 689 | 2091 | 0.3294 | 0.5729 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 28.21 | 84.90 | 1018 | 2091 | 0.4867 | 0.7115 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.92 | 84.90 | 21 | 2237 | 0.0094 | -0.2562 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.92 | 84.90 | 791 | 2237 | 0.3535 | 0.6045 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.92 | 84.90 | 736 | 2237 | 0.3289 | 0.5802 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 29.92 | 84.90 | 1042 | 2237 | 0.4657 | 0.7010 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 31.62 | 84.90 | 22 | 2449 | 0.0090 | -0.2430 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 31.62 | 84.90 | 868 | 2449 | 0.3543 | 0.6149 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 31.62 | 84.90 | 746 | 2449 | 0.3045 | 0.5652 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 31.62 | 84.90 | 1134 | 2449 | 0.4629 | 0.7064 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 33.32 | 84.90 | 17 | 2722 | 0.0062 | -0.2749 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 33.32 | 84.90 | 971 | 2722 | 0.3567 | 0.6276 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 33.32 | 84.90 | 695 | 2722 | 0.2553 | 0.5223 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 33.32 | 84.90 | 1143 | 2722 | 0.4199 | 0.6815 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.03 | 84.90 | 18 | 2991 | 0.0060 | -0.2605 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.03 | 84.90 | 987 | 2991 | 0.3300 | 0.6119 | MN20160318_Q02 | J14 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.03 | 84.90 | 550 | 2991 | 0.1839 | 0.4385 | MN20160318_Q02 | K04 |
| MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 35.03 | 84.90 | 1142 | 2991 | 0.3818 | 0.6583 | MN20160318_Q02 | K04 |